Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
What the hell is CHIP and why do I need to know about it?
Check out this rapid summary by the talented and creative Tiffany Caza!
Did you miss the last #NephJC? Check out this #TenTweetNephJC to catch up! pic.twitter.com/7oT34h2vzx
— Nephrology Jrnl Club (@NephJC) May 24, 2022
NSMC intern Mohamed Ibrahim created a beautiful visual abstract which simplifies the findings of CHIP study.
